News / Taiwan / cnyes
Taiwan Life Injects 500 Million RMB into Junlong Life to Bolster China Expansion
Finance · Life/Health Insurance · cnyes · 2026-08-27
2891
CTBC Financial's subsidiary, Taiwan Life, is participating in a 500 million RMB capital injection for its joint venture, Junlong Life, to strengthen its capital base and support growth in the Chinese insurance market.
What Happened
Capital Injection: Taiwan Life, a subsidiary of CTBC Financial, has approved a 500 million RMB capital injection into its joint venture, Junlong Life, pending regulatory approval from both Taiwan and China.
Joint Venture Structure: Established in 2008 as a 50-50 partnership between Taiwan Life and Xiamen C&D Group, the total capital increase of 1 billion RMB will bring Junlong Life's total capital to 3.6 billion RMB.
Operational Growth: Since joining CTBC Financial in 2015, Junlong Life has seen consistent growth, with assets exceeding 10 billion RMB and record-high profits, marking a significant milestone in its 17-year history.
Strategic Focus: To address China's aging population and healthcare needs, Junlong Life plans to expand its differentiated service offerings, focusing on integrating insurance with medical and elderly care solutions.